Found 4 matching trials
Study to Compare the Safety and Efficacy of CMB305 With Atezolizumab to Atezolizumab Alone in Participants With Sarcoma (IMDZ-C232/V943A-002) PHASE2 This is an open-label Phase 2 randomized study that will examine the use of...
Show More Location
Stanford University Medical Center
Learn More & Join Trial
Modified T Cells, Chemotherapy, and Aldesleukin With or Without LV305 and CMB305 in Treating Participants With Advanced or Recurrent Sarcoma PHASE1 This phase I trial studies how well autologous NY-ESO-1-specific CD8-positi...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
A Phase 3, Randomized, Double-blind, Placebo-controlled Study For Subjects With Locally-advanced Unresectable or Metastatic Synovial Sarcoma (V943-003, IMDZ-04-1702) PHASE3 To assess if the CMB305 vaccine regimen may help the body's immune system t...
Show More Location
Mayo Clinic- Scottsdale
Learn More & Join Trial
Phase 1b Safety Study of CMB305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1 PHASE1 This is a Phase 1b, open label, multi-center study of CMB305 (sequentially ...
Show More Location
Sarcoma Oncology Center
Learn More & Join Trial